William J Muller (William Muller)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Top Venues

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Ipshita Nandi, Linjia Ji, Harvey W Smith, Daina Avizonis, Vasilios Papavasiliou, Cynthia Lavoie, Alain Pacis, Sherif Attalla, Virginie Sanguin-Gendreau, William J Muller
Targeting fatty acid oxidation enhances response to HER2-targeted therapy. Nature communications 15 (1) (2024)
Ipshita Nandi, Linjia Ji, Harvey W Smith, Daina Avizonis, Vasilios Papavasiliou, Cynthia Lavoie, Alain Pacis, Sherif Attalla, Virginie Sanguin-Gendreau, William J Muller
Targeting fatty acid oxidation enhances response to HER2-targeted therapy. Nature communications 15 (1) (2024)
Ipshita Nandi, Linjia Ji, Harvey W Smith, Daina Avizonis, Vasilios Papavasiliou, Cynthia Lavoie, Alain Pacis, Sherif Attalla, Virginie Sanguin-Gendreau, William J Muller
Targeting fatty acid oxidation enhances response to HER2-targeted therapy. Nature communications 15 (1) (2024)
Sherif Samer Attalla, Jonathan Boucher, Hailey Proud, Tarek Taifour, Dongmei Zuo, Virginie Sanguin-Gendreau, Chen Ling, Gabriella Johnson, Vincent Li, Robin B Luo, Hellen Kuasne, Vasilios Papavasiliou, Logan A Walsh, Mark Barok, Heikki Joensuu, Morag Park, Philippe P Roux, William J Muller
HER2∆16 Engages ENPP1 To Promote an Immune Cold Microenvironment in Breast Cancer. Cancer immunology research (2023)
Zheqi Li, Olivia McGinn, Yang Wu, Amir Bahreini, Nolan M Priedigkeit, Kai Ding, Sayali Onkar, Caleb Lampenfeld, Carol A Sartorius, Lori Miller, Margaret Rosenzweig, Ofir Cohen, Nikhil Wagle, Jennifer K Richer, William J Muller, Lakjaya Buluwela, Simak Ali, Tullia C Bruno, Dario A A Vignali, Yusi Fang, Li Zhu, George C Tseng, Jason Gertz, Jennifer M Atkinson, Adrian V Lee, Steffi Oesterreich
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation. Nature communications 13 (1) (2022)
Catherine Rosa Dufour, Hui Xia, Wafa B'chir, Marie-Claude Perry, Uros Kuzmanov, Anastasiia Gainullina, Kurt Dejgaard, Charlotte Scholtes, Carlo Ouellet, Dongmei Zuo, Virginie Sanguin-Gendreau, Christina Guluzian, Harvey W Smith, William J Muller, Etienne Audet-Walsh, Alexey A Sergushichev, Andrew Emili, Vincent Giguère
Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency. Communications biology 5 (1) (2022)
Alexandra M Simond, Tung Bui, Dongmei Zuo, Virginie Sanguin-Gendreau, Trisha Rao, Wayne A Phillips, Robert D Cardiff, William J Muller
Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer. Oncogene 41 (25) (2022)
Yu Gu, Tung Bui, William J Muller
Exploiting Mouse Models to Recapitulate Clinical Tumor Dormancy and Recurrence in Breast Cancer. Endocrinology 163 (6) (2022)
Tung Bui, Yu Gu, Frédéric Ancot, Virginie Sanguin-Gendreau, Dongmei Zuo, William J Muller
Emergence of β1 integrin-deficient breast tumours from dormancy involves both inactivation of p53 and generation of a permissive tumour microenvironment. Oncogene (2021)
Sherif Samer Attalla, Tarek Taifour, Tung Bui, William J Muller
Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo. Oncogene 40 (3) (2020)